Is that the reason why Cellectar Biosciences, Inc. (CLRB), stock muddled in the post market hours Tuesday?
Cellectar Biosciences, Inc. (NASDAQ:CLRB), shares were dipping -22.38% to $2.15 in the after-hours session on Tuesday after the company, focused on the discovery, development and commercialization of new cancer therapies, Cellectar Biosciencesannounced that it plans to offer and sell shares of its common stock and its common stock equivalents in a public offering. There is […]